Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2471-2480 of 10853

Edit search filters
  1. A Study to Investigate the Performance of Dual Energy CT for the Detection of Breast Implant Rupture and Extra-capsular Silicone Compared to Standard MRI Exams.

  2. Randomized Global Phase 3 Study to Evaluate the Impact of Obeticholic Acid Treatment on Nonalcoholic Steatohepatitis Patients

    Rochester, MN

  3. Pediatric Home Tube Feeding, the Impact of Nutrition Intervention Prior to Tube Placement

    Rochester, MN

  4. Smart Fabric for Cardio-Performance Enhancement

    Rochester, MN

  5. Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)

    Rochester, MN

  6. A Study to Evaluate the Use of MANP in Patients with Hypertension and Metabolic Syndrome

    Rochester, MN

  7. A Study of Nervous System Response to Changes in Blood Pressure and Carbon Dioxide Levels

    Rochester, MN

  8. Early Identification of Chemotherapy Induced Cardiac Toxicity

    Rochester, MN

  9. The Influence of Pedal Rate on Activation of Locomotor Afferents and Cardiovascular Responses

    Rochester, MN

  10. Effectiveness of Departmental Education on Reducing 5% Albumin Administration

    Rochester, MN

.

Mayo Clinic Footer